Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Intro to PCOR - Defining it for the RUNX1-FPD Community Next Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24) You Might Also Like "Mechanisms underlying aging associated increased heterogeneity and selection for clonal hematopoiesis mutations in hematopoietic stem cell pools." RUNX1 Patient Data Hub: Getting Started on Matrix Introduction To The Stem Cell Harvesting & Banking Clinical Trial RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham Part 2: April 2025 Sirolimus Study Update Patient Participants Perspectives and Q&A
Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Intro to PCOR - Defining it for the RUNX1-FPD Community Next Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24) You Might Also Like "Mechanisms underlying aging associated increased heterogeneity and selection for clonal hematopoiesis mutations in hematopoietic stem cell pools." RUNX1 Patient Data Hub: Getting Started on Matrix Introduction To The Stem Cell Harvesting & Banking Clinical Trial RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham Part 2: April 2025 Sirolimus Study Update Patient Participants Perspectives and Q&A
